BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $102,000 | +8.5% | 87,000 | +16.0% | 0.00% | – |
| Q3 2016 | $94,000 | -35.2% | 75,000 | -40.0% | 0.00% | – |
| Q2 2016 | $145,000 | -2.0% | 125,000 | 0.0% | 0.00% | – |
| Q1 2016 | $148,000 | -11.4% | 125,000 | 0.0% | 0.00% | – |
| Q4 2015 | $167,000 | -0.6% | 125,000 | 0.0% | 0.00% | – |
| Q3 2015 | $168,000 | -15.6% | 125,000 | 0.0% | 0.00% | – |
| Q2 2015 | $199,000 | – | 125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
| Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
| MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
| IRON Financial LLC | 430,000 | $446,000 | 0.33% |
| RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
| Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
| Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |